The Sickle Cell Disease Association of America (SCDAA) is collaborating with Emmaus Life Sciences to increase patient education…
Articles by Margarida Azevedo, MSc
MaxCyte, a company specialized in cell-based medicines, announced it has entered in a research agreement with the National Heart,…
The U.S. Food and Drug Administration (FDA) recently granted orphan drug status to olinciguat (IW-1701) as a potential treatment of…
The Vodafone Americas Foundation recently announced the winners of its 10th annual Wireless Innovation Project (WIP), which awarded $600,000…
The U.S. Food and Drug Administration placed a clinical hold on the investigational new drug (IND) application for CTX001,…
A significant proportion of children with sickle cell disease (SCD) are not receiving key recommended vaccines on time or…
The U.S. Food and Drug Administration recently accepted an investigational new drug (IND) application submitted by Bioverativ and…
Physicians who use stigmatizing language in their patients’ medical records could be affecting the care they receive for years to…
Three programs focused on sickle cell disease (SCD) planned by St. Jude Children’s Research Hospital will benefit from a $1…
At least 800 people representing some 45 countries are soon expected to gather in Austria’s capital city, Vienna, for…